Back

The prognostic value of normal troponin on admission in STEMI patients: an 8-year multicenter cohort

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (5) Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ohad Stoler

Baruch Padeh Medical Center, Tiberias (Israel)

5 More presentations in this session

Presentation thumbnail
Hs-CRP is a strong predictor of adverse cardiovascular events in patients with chest pain
Doctor B. Toprak (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Cardiac troponin elevations across non-cardiac diseases: a comprehensive analysis
Ms S. Knudsen (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Prognostic value of cardiovascular biomarkers in patients with suspected coronary artery disease
Doctor B. Abdennadher (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
The relationship between peak serum creatine kinase levels after PCI and long-term outcomes in patients with STEMI: a report from the STELA registry
Doctor Y. Matsuda (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Lp(a) measurement in younger patients following ST-elevation myocardial infarction: insights from a contemporary regional registry.
Doctor N. Atefi (Vancouver, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (5)

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
The prognostic utility of troponin T levels in patients undergoing PCI during initial hospitalisation for STEMI
thumbnail
Congress Presentation
Sex-Differences in Long-term Mortality in Patients with ST-Segment elevation myocardial infarction with and without obstructive coronary arteries
thumbnail
Congress Presentation
5-year mortality after ST-segment elevation myocardial infarction compared to the general population

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources